Researchers have conducted a comprehensive review on immune aging, focusing on its implications for vulnerability to respiratory infections, particularly influenza. The study highlights the dual challenges posed by age-related declines in immune competence, characterized by reduced production of new immune cells, and the paradoxical increase in inflammatory responses. This combination creates an environment where pathogens can more easily evade immune defenses, while the heightened inflammation can lead to severe complications during infections.

The review emphasizes the significance of immunosenescence and inflammageing—two critical processes that contribute to the deterioration of immune function in older adults. As the global population ages, with projections indicating that those aged 60 and above will reach approximately 2.1 billion by 2050, the healthcare implications of these phenomena become increasingly urgent. The authors detail how the structural degradation of immune organs and the dysregulation of both innate and adaptive immune responses elevate the risk of adverse outcomes from infections, notably respiratory viral infections, which are particularly deadly in this demographic.

A key takeaway from this review is the identification of potential biomarkers and strategies for intervention aimed at mitigating the effects of immunosenescence. This could shift current research paradigms by emphasizing the need for targeted therapies and preventive measures that address the unique vulnerabilities of older adults. As the field progresses, understanding these mechanisms will be crucial for developing effective treatments and improving healthspan, ultimately reducing the burden of infectious diseases in aging populations.

Source: fightaging.org